Good response on adalimumab treatment for patients with rheumatoid arthritis persists for up to 9 years

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2016
This article has no abstract
Epistemonikos ID: 831547cf7201578ebae5285b4742711de3fac08b
First added on: Feb 07, 2025